To that end we have shown that caspase-1-dependent IL1β production is a defining feature of TNBC that drives the recruitment of pro-tumoral TAMs, the exclusion of CD8+ T cells from the tumor core, tumor growth, and resistance to anti-PD1 immunotherapy. The gene discussed is PDCD1; the disease is neoplasm.